vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Armada Hoffler Properties, Inc. (AHH). Click either name above to swap in a different company.

Armada Hoffler Properties, Inc. is the larger business by last-quarter revenue ($75.6M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). Armada Hoffler Properties, Inc. runs the higher net margin — 3.1% vs -19.9%, a 23.1% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 0.8%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -22.8%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Armada Hoffler Properties, Inc. is a publicly traded U.S. real estate investment trust operating across the Mid-Atlantic and Southeast regions. It develops, owns, and manages a diversified portfolio of office, retail, and multifamily residential properties, and also offers construction and development services for third-party clients.

ABCL vs AHH — Head-to-Head

Bigger by revenue
AHH
AHH
1.7× larger
AHH
$75.6M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+787.6% gap
ABCL
788.4%
0.8%
AHH
Higher net margin
AHH
AHH
23.1% more per $
AHH
3.1%
-19.9%
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-22.8%
AHH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
AHH
AHH
Revenue
$44.9M
$75.6M
Net Profit
$-8.9M
$2.4M
Gross Margin
Operating Margin
-63.7%
31.0%
Net Margin
-19.9%
3.1%
Revenue YoY
788.4%
0.8%
Net Profit YoY
73.9%
-89.8%
EPS (diluted)
$-0.03
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
AHH
AHH
Q4 25
$44.9M
$75.6M
Q3 25
$9.0M
$72.7M
Q2 25
$17.1M
$69.1M
Q1 25
$4.2M
$67.8M
Q4 24
$5.0M
$75.0M
Q3 24
$6.5M
$114.4M
Q2 24
$7.3M
$116.8M
Q1 24
$10.0M
$127.0M
Net Profit
ABCL
ABCL
AHH
AHH
Q4 25
$-8.9M
$2.4M
Q3 25
$-57.1M
$80.0K
Q2 25
$-34.7M
$5.9M
Q1 25
$-45.6M
$-2.8M
Q4 24
$23.4M
Q3 24
$-51.1M
$-5.0M
Q2 24
$-36.9M
$3.2M
Q1 24
$-40.6M
$14.1M
Gross Margin
ABCL
ABCL
AHH
AHH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
45.0%
Q2 24
41.8%
Q1 24
37.9%
Operating Margin
ABCL
ABCL
AHH
AHH
Q4 25
-63.7%
31.0%
Q3 25
-851.8%
29.2%
Q2 25
-290.2%
29.6%
Q1 25
-1479.6%
23.2%
Q4 24
50.1%
Q3 24
-1439.4%
19.0%
Q2 24
-1276.2%
11.9%
Q1 24
-551.5%
15.1%
Net Margin
ABCL
ABCL
AHH
AHH
Q4 25
-19.9%
3.1%
Q3 25
-637.8%
0.1%
Q2 25
-203.3%
8.6%
Q1 25
-1077.2%
-4.1%
Q4 24
31.2%
Q3 24
-785.4%
-4.4%
Q2 24
-504.3%
2.7%
Q1 24
-408.0%
11.1%
EPS (diluted)
ABCL
ABCL
AHH
AHH
Q4 25
$-0.03
$0.00
Q3 25
$-0.19
$-0.04
Q2 25
$-0.12
$0.04
Q1 25
$-0.15
$-0.07
Q4 24
$0.28
Q3 24
$-0.17
$-0.11
Q2 24
$-0.13
$0.00
Q1 24
$-0.14
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
AHH
AHH
Cash + ST InvestmentsLiquidity on hand
$128.5M
$49.1M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$966.9M
$627.8M
Total Assets
$1.4B
$2.6B
Debt / EquityLower = less leverage
2.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
AHH
AHH
Q4 25
$128.5M
$49.1M
Q3 25
$83.2M
$46.5M
Q2 25
$92.4M
$52.1M
Q1 25
$159.3M
$45.7M
Q4 24
$156.3M
$31.9M
Q3 24
$126.6M
$43.9M
Q2 24
$148.3M
$20.3M
Q1 24
$123.6M
$41.9M
Total Debt
ABCL
ABCL
AHH
AHH
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
ABCL
ABCL
AHH
AHH
Q4 25
$966.9M
$627.8M
Q3 25
$964.0M
$638.8M
Q2 25
$1.0B
$652.0M
Q1 25
$1.0B
$657.4M
Q4 24
$1.1B
$670.6M
Q3 24
$1.1B
$663.9M
Q2 24
$1.1B
$562.7M
Q1 24
$1.1B
$571.4M
Total Assets
ABCL
ABCL
AHH
AHH
Q4 25
$1.4B
$2.6B
Q3 25
$1.4B
$2.6B
Q2 25
$1.4B
$2.6B
Q1 25
$1.3B
$2.5B
Q4 24
$1.4B
$2.5B
Q3 24
$1.4B
$2.6B
Q2 24
$1.4B
$2.6B
Q1 24
$1.5B
$2.6B
Debt / Equity
ABCL
ABCL
AHH
AHH
Q4 25
2.43×
Q3 25
2.33×
Q2 25
2.22×
Q1 25
2.01×
Q4 24
1.93×
Q3 24
2.00×
Q2 24
2.52×
Q1 24
2.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
AHH
AHH
Operating Cash FlowLast quarter
$-34.7M
$64.2M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
26.99×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
AHH
AHH
Q4 25
$-34.7M
$64.2M
Q3 25
$-52.6M
$26.3M
Q2 25
$-32.4M
$11.1M
Q1 25
$-11.6M
$107.0K
Q4 24
$-108.6M
$112.0M
Q3 24
$-28.9M
$27.3M
Q2 24
$-30.0M
$17.4M
Q1 24
$-41.7M
$46.5M
Free Cash Flow
ABCL
ABCL
AHH
AHH
Q4 25
$-44.6M
Q3 25
$-61.5M
Q2 25
$-45.8M
Q1 25
$-22.2M
Q4 24
$-187.0M
Q3 24
$-47.4M
Q2 24
$-50.1M
Q1 24
$-65.8M
FCF Margin
ABCL
ABCL
AHH
AHH
Q4 25
-99.4%
Q3 25
-687.0%
Q2 25
-267.9%
Q1 25
-524.0%
Q4 24
-3702.8%
Q3 24
-728.4%
Q2 24
-683.8%
Q1 24
-661.5%
Capex Intensity
ABCL
ABCL
AHH
AHH
Q4 25
21.9%
Q3 25
99.7%
Q2 25
78.2%
Q1 25
251.1%
Q4 24
1552.7%
Q3 24
284.6%
Q2 24
274.6%
Q1 24
242.5%
Cash Conversion
ABCL
ABCL
AHH
AHH
Q4 25
26.99×
Q3 25
328.63×
Q2 25
1.87×
Q1 25
Q4 24
4.78×
Q3 24
Q2 24
5.48×
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

AHH
AHH

Office Real Estate Segment$28.8M38%
Retail Real Estate Segment$25.4M34%
Multifamily Residential Real Estate$17.7M23%
Real Estate Financing Segment$3.6M5%

Related Comparisons